Ignite Creation Date:
2025-12-24 @ 4:05 PM
Ignite Modification Date:
2026-02-20 @ 10:44 PM
Study NCT ID:
NCT01328366
Status:
COMPLETED
Last Update Posted:
2015-07-09
First Post:
2011-04-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Quality of Life and Psychosocial Factors Associated With Severe Psoriasis Following Treatment With Adalimumab
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-05
Start Date Type:
None
Primary Completion Date:
2014-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-05
Completion Date Type:
ACTUAL
First Submit Date:
2011-04-01
First Submit QC Date:
None
Study First Post Date:
2011-04-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-05-29
Results First Submit QC Date:
None
Results First Post Date:
2015-06-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-06-11
Last Update Post Date:
2015-07-09
Last Update Post Date Type:
ESTIMATED